Gallant Partners with MWI on FDA-Approved Stem Cell Therapy
27 Feb 2026 //
PR NEWSWIRE
FDA Clears Gallant`s Stem Cell Therapy For Refractory FCGS
10 Nov 2025 //
PR NEWSWIRE BIO
Gallant Completes FDA "technical Section" For Stem Cell Therapy
23 Sep 2025 //
PR NEWSWIRE
Gallant Adds Animal Health Executive Aaron Schacht to Board of Directors
06 Feb 2024 //
GLOBENEWSWIRE
Gallant Therapeutics Raises Over $15 Million in Series A Funding
08 Jan 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support